IJMS | Free Full-Text | Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator in Respiratory Disease
EXO-CD24 - Israeli drug effective against coronavirus | Madan
Non si conosce ancora l'efficacia del farmaco israeliano “Exo-Cd24” contro la Covid-19 - Facta
EXO-CD24 and the Treatment of COVID-19 - Creative Diagnostics
A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine
Frontiers | CD24-Siglec interactions in inflammatory diseases
A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine
CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemi | OTT
EXO-CD24, el fármaco israelí que asegura curar el coronavirus en pacientes graves en 5 días
Frontiers | The biological roles of CD24 in ovarian cancer: old story, but new tales
EXO-CD24: ¿Reduce la mortalidad por Covid-19 esta nueva estrategia terapéutica?
IJMS | Free Full-Text | Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator in Respiratory Disease
A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine
A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine
EXO-CD 24 Aparece una luz en el tratamiento del Covid 19 – Gestión y Economía de la Salud
Clinical characteristics of the patients as baseline. EXO-CD24 Dose | Download Scientific Diagram
A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine
Radio Cadena Voces on X: "#RCVInternacional El tratamiento, llamado EXO-CD24, es administrado directo a los pulmones para eliminar daños generados por covid Dato: 29 de 30 pacientes con COVID-19 en condición moderada
COVID: Nadir Arber, l'Israélien à l'origine de l'EXO-CD24, "médicament miracle" - The Times of Israël
EXO-CD24: Israeli Doctors Present Innovative Drug for COVID-19 Treatment - Georgia Today
EXO-CD24: Israeli Doctors Present Innovative Drug for COVID-19 Treatment - Georgia Today
Likelihood of Approval and Phase Transition Success Rate Model - EXO-CD24 in Acute Respiratory Distress Syndrome - Market Research Reports & Consulting | GlobalData UK Ltd.
EXO-CD24 | The Times of Israel
CD24: A Key Element in the EXO-CD24 Technique for Combating COVID-19- CUSABIO
Targeting CD24 as a novel immunotherapy for solid cancers | Cell Communication and Signaling | Full Text
